Prevalence of dyslipidemias in autoimmune rheumatic diseases

Journal of the College of Physicians and Surgeons Pakistan

Volumn 22, Issue 4, 2012, Pages 235-239

  Nisar, Anila ^a   Rasheed, Uzma ^a   Aziz, Wajahat ^a   Farooqi, Abid Zaheer ^a  

^a PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

Autoimmune rheumatic disease; Cardiovascular disease; Dyslipidemia; Rheumatoid arthritis; Total cholesterol

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PAKISTAN; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; RISK FACTORS; YOUNG ADULT;

EID: 84864397143     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Spellman CW. Strategies for optimizing lipid treatment outcomes. J Am Osteopath Assoc 2003; 103:S12-5.
2. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112:3337-47.
3. Turesson C, Jacobsson LT, Matteson EL. Cardiovascular comorbidity in rheumatic diseases. Vasc Health Risk Manag 2008; 4:605-14.
4. Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 2006; 5:331-7. Epub 2006 Feb 3.
5. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, et al. Atherosclerosis in rheumatoid arthritis versus diabetes. Arterioscler Thromb Vasc Biol 2009; 29:1702-8. Epub 2009 Jul 16.
6. Frostegard J. Atherosclerosis in patients with autoimmune diseases. Arterioscler Thromb Vasc Biol 2005; 25:1776-85. Epub 2005 Jun 23.
7. Toms TE, Panoulas VF, Kitas GD. Dyslipidemia in rheumatological autoimmune diseases. Open Cardiovasc Med J 2011; 5:64-75. Epub 2011 Feb 24.
8. Choy E, Sattar N. Interpreting lipid levels in the context of high grade inflammatory states with a focus on rheumatoid arthritis. Ann Rheum Dis 2009; 68:460-9.
9. Nurmohamed MT. Atherogenic lipid profile and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 2007; 3:845-52.
10. Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2008; 38:372-81. Epub 2008 Apr 18.
11. Kowsalya R, Sreekantha, Chandran V, Remya. Dyslipidemia with altered oxidant: antioxidant status in rheumatoid arthritis. Int J Pharm Bio Sci 2011; 2:424-8.
12. Klippel JH, Stone JH, Crofford LJ, White PH, editors. Primer on the rheumatic diseases. 13th ed. New York: Springerlink; 2008.
13. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26:S35-61.
14. Shah SZA, Devrajani BR, Devrajani T, Bibi I. Frequency of dyslipidemia in obese versus non-obese in relation to body mass index (BMI), waist hip ratio (WHR) and waist circumference (WC). Pak J Sci 2010; 62:27-31.
15. Iqbal SP, Dodani S, Qureshi R. Risk factors and behaviours for coronary artery disease (CAD) among ambulatory Pakistanis. J Pak Med Assoc 2004; 54:261-6.
16. Basit A, Shera AS. Prevalence of metabolic syndrome in Pakistan. Metab Syndr Relat Disord 2008; 6:171-5.
17. Estari M, Reddy AS, Bikshapathi T, Satyanarayana J, Venkanna L, Reddy MK. The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India. Biol Med 2009; 1:61-5.
18. Hadda V, Handa R, Aggarwal P, Lakshmiy R, Umar UK, Pandey RM. Disease activity and lipids in rheumatoid arthritis: a prospective study. Indian J Rheum 2007; 2:137-40.
19. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment: a prospective, controlled study. Arthritis Res Ther 2006; 8:R82.
20. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz- Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011; 70:482-7.
21. Cesur M, Ozbalkan Z, Temel MA, Karaarslan Y. Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis. Clin Rheumatol 2007; 26:355-61. Epub 2006 May 6.